Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C, Khouri I, Andersson B, Gajewski J, Donato M, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin R.

Blood. 2004 Aug 1;104(3):649-54. Epub 2004 Apr 6.

3.

Infliximab for steroid-refractory acute GVHD: a case series.

Jacobsohn DA, Hallick J, Anders V, McMillan S, Morris L, Vogelsang GB.

Am J Hematol. 2003 Oct;74(2):119-24.

4.

Infliximab treatment for steroid-refractory acute graft-versus-host disease.

Patriarca F, Sperotto A, Damiani D, Morreale G, Bonifazi F, Olivieri A, Ciceri F, Milone G, Cesaro S, Bandini G, Dini G, Corradini P, Fanin R.

Haematologica. 2004 Nov;89(11):1352-9.

6.

Infliximab for GVHD therapy in children.

Sleight BS, Chan KW, Braun TM, Serrano A, Gilman AL.

Bone Marrow Transplant. 2007 Sep;40(5):473-80. Epub 2007 Jul 9.

PMID:
17618323
7.

Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses.

Korngold R, Marini JC, de Baca ME, Murphy GF, Giles-Komar J.

Biol Blood Marrow Transplant. 2003 May;9(5):292-303.

8.

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

Hervé P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E, et al.

Blood. 1992 Jun 15;79(12):3362-8.

9.

Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other interleukin-2 receptor antibodies.

Bay JO, Dhédin N, Goerner M, Vannier JP, Marie-Cardine A, Stamatoullas A, Jouet JP, Yakoub-Agha I, Tabrizi R, Faucher C, Diez-Martin JL, Nunez G, Parody R, Milpied N, Espérou H, Garban F, Galambrun C, Kwiatkovski F, Darlavoix I, Zinaï A, Fischer A, Michallet M, Vernant JP.

Transplantation. 2005 Sep 27;80(6):782-8.

PMID:
16210965
11.

Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host disease.

Kokalj A, Greinix HT, Ciovica M, Kittler H, Kalhs P, Knobler RM, Volc-Platzer B.

Clin Immunol. 2002 Sep;104(3):248-55.

PMID:
12217335
12.
13.

Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients.

Racadot E, Milpied N, Bordigoni P, Cahn JY, Plouvier E, Lioure B, Lutz P, Wijdenes J, Herve P.

Bone Marrow Transplant. 1995 May;15(5):669-77.

PMID:
7670394
14.

A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.

Takabayashi M, Kanamori H, Takasaki H, Yamaji S, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujisawa S, Maruta A, Ishigatsubo Y.

Exp Hematol. 2005 Feb;33(2):251-7.

PMID:
15676220
15.
16.

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.

Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A.

Am J Hematol. 2005 Apr;78(4):265-74.

18.

Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.

Hervé P, Racadot E, Wijdenes J, Flesch M, Tiberghien P, Bordigoni P, Holler E, Powles M, Bourdeau M, Wilmer E, et al.

Bone Marrow Transplant. 1991;7 Suppl 2:149. No abstract available.

PMID:
1878688
19.

Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation.

Jaksch M, Uzunel M, Martinez Cangana G, Remberger M, Mattsson J.

Bone Marrow Transplant. 2003 Feb;31(3):183-90.

PMID:
12621479
20.

Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.

Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, Deconinck E, Hillon P, Di Martino V.

Liver Transpl. 2009 Jul;15(7):682-5. doi: 10.1002/lt.21793.

Supplemental Content

Support Center